Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

ILC1 cells contribute to hair loss in alopecia areata.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

LED-LLLT helps heal wounds, reduce pain, and regrow hair using specific light wavelengths.

Poly-L-lactic acid injections can cause hair loss and skin issues.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Baricitinib may effectively treat oral lichen planus.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Strict regulations may slow down new LLLT treatments.

A man developed an allergic skin reaction from a therapy cap used for hair loss treatment.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Helmet-like device safely increases hair density for people with hair loss.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.